Congress Schedule

Hosted in the Faculty Lounge, with an outside terrace of the Allard School of Law, where the pre-conference educational seminars are held, doors will be open from 5:30 pm -9 pm. You can also pick up your commerative glass celebrating IIRRM’s 20th Annual Meeting & Congress.

Gold and Silver sponsor exhibits will be open in the Allard foyer in the late afternoon.  Map of Allard Hall here.

Come and mingle for snacks through the evening.  No formal dinner is planned, but we encourage attendees to explore the restaurants on campus or take a walk down to Spanish Banks Beach for sunset. Most on-campus accommodation has kitchens and group lounges. We will begin wrapping up and clean up around 9:15pm.

Dr. Boyle trained in NaProTechnology before developing NeoFertility in 2016. Dr. Boyle is president of the IIRRM (International Institute for Restorative Reproductive Medicine). He runs a fertility clinic in Dublin, Ireland, and has successfully treated over 3000 pregnancies, many patients with years of infertility, repeated miscarriage and unsuccessful IVF. He is currently researching the effectiveness of estrogen treatment to reduce the risk of miscarriage and premature delivery

Dr. Lind is board-certified in Internal Medicine and Pediatrics and Certified in functional medicine through the Institute for Functional Medicine. Dr. Lind completed her medical training at the University of Minnesota and has a Master’s in Physiology and Biophysics at Georgetown University. She has spent over 20 years in primary care and hospital medicine. Dr. Lind is a Certified Medical Consultant for the Creighton Model FertilityCare System. She is also trained in FEMM as a Reproductive Health Research Institute (RHRI) fellow.

Identify evidence-based thresholds for Mira Monitor protocols in the Marquette Method and identify challenges with teaching couples how to interpret quantitative hormone results.  Additionally, the presentation explores the nuanced differences in utilizing quantitative monitors across various circumstances, including postpartum, regular cycles, and perimenopause, etc., providing valuable guidance for clinicians and educators in the field.

This presentation gives insights into the detection and diagnosis of endometriosis, addressing both future risk assessment and current identification of potential cases. Learn to accurately diagnose patients with deep endometriosis, effective strategies for identifying patients at risk of developing endometriosis, recognizing those already affected by the condition, and when to operate on patients with endometriosis.

Review the goal of endometriosis surgery focusing on the restoration of normal anatomy and its impact on pain and fertility outcomes. This session will explore the goals, evidence, and controversies surrounding surgical interventions for endometriosis, as well as adjunct therapies aimed at optimizing patient outcomes.

Dr. Jose Antonio Arraztoa specializes in obstetrics and gynecology holds a master’s degree in reproductive biology as well as health management, and completed a research fellowship in reproductive endocrinology at NICHD/NIH. Since 1996 he has been a professor in the department of obstetrics and gynecology at the Universidad de los Andes, where he has developed his academic career, currently being a Full Professor. He is the founder and current director of the Program for the Care and Study of Fertility (PROCEF) of the Universidad de los Andes, and Deputy Medical Director at the Universidad de los Andes.

The presentation discusses inducing ovulation and achieving successful pregnancies in women seemingly in total menopause, highlighting methods to enhance follicle sensitivity to FSH, with compounded ethinyl estradiol being the cost-effective approach. It emphasizes the importance of supplemental progesterone, particularly vaginally, to maximize pregnancy success post-ovulation induction. Additionally, it addresses instances where additional FSH stimulation is necessary and outlines the conditions and dosage requirements for such interventions.

This presentation delves into the endocannabinoid system (ECS) and its components and the impact on reproductive health.  Learn to identify and distinguish how the ECS components affect reproductive health, and identify specific pathologies of the ECS observed in common reproductive conditions.

The multifactorial nature of infertility is well-established. Immunological infertility is a prime example of a complex etiology of infertility. The mechanisms at play hinder optimal hormonal balance, contribute to progesterone resistance, and jeopardize full-term pregnancies.

This lecture explores the safe and effective merging of Botanical and Allopathic Pharmacology to enhance clinical outcomes. They work synergistically to address obstacles to cure by:

• Normalizing the immune response
• Reducing gynecological inflammation
• Restoring fertility in your patients

The Pharmaceutical Medications discussed include:

• Bio-identical progesterone, HCG, LDN, and Tumour Necrosis Factor Inhibitors
• Bio-identical progesterone and HCG are used to overcome progesterone deficiency, support the endometrium, improve implantation, and support a full-term pregnancy
• LDN and TNFIs help modulate the immune system

Relevant Pharmacological Mode of Actions in the literature include:

• Modulating Tumour Necrosis Factor, IL-6, and IL-1

Applicable natural therapeutics in the literature include:

• Baical Skullcap, Turmeric, Chaste Tree, Ginger, Panax Ginseng, Resveratrol, Berberine, and Pycnogenol

Cases will be discussed and accompanied by Menstrual Cycle Charts to present a visual representation of changes seen before and after treatment.

Explore the relationship between sleep and reproductive health, uncovering how sleep quality impacts fertility, menstrual health, and pregnancy outcomes. Learn evidence-based strategies to optimize sleep quality and achieve better reproductive outcomes